A hidden cause of the reproducibility crisis is how researchers select models like cell lines or mice. The choice is often driven by convenience—what a neighboring lab has available—rather than a systematic evaluation of which model is best suited to answer the specific scientific question.

Scaling up a bioprocess from lab to production fundamentally alters physical properties like oxygen transfer (KLA). This change in physics, not necessarily a procedural mistake, is often the root cause of failure at scale, leading to different cell growth and product quality.

As AI and automation become central to drug discovery, the physical layout and infrastructure of a lab are no longer just a facility. They are a core competitive advantage, an "experiment upon themselves" that companies actively protect as valuable IP to prevent replication by rivals.

Teams hyper-focus on replicating process parameters during tech transfer, but this is a blind spot. The true measure of success is a statistically powerful analytical and sampling plan that rigorously proves the process transferred successfully and can detect any deviations.

Critical process knowledge often exists only in operators' heads—the nuances and undocumented tricks that ensure success. Systematically capturing this 'tribal knowledge' during tech transfer is crucial for preventing hard-to-diagnose failures at the new site.

Seemingly technical roadblocks during tech transfer, like an uncooperative QC manager, often mask underlying human issues like burnout or being understaffed. Addressing the human need (e.g., for predictability) is the fastest way to solve the technical bottleneck.

The most common failure in automation is focusing on the robot or software. True success is determined by deeply understanding and codifying the entire process, including its environment and inherent variabilities. Getting the requirements right is the core challenge; the technology itself is secondary.

A key benefit of autonomous labs isn't just speed but perfect documentation. AI-driven systems eliminate human variability—like slight changes in pipetting angle—that is impossible to document but critical for reproducibility. This creates the pristine, detailed data needed for advanced AI models to learn effectively.

When scaling to production, the biggest pitfall is the implicit knowledge held by the original design team who unconsciously fill procedural gaps. To succeed, involve someone with a manufacturing background but no project history to rigorously review procedures and expose these unstated assumptions before scaling.